Fogarty International Center; Notice of Meeting, 22148-22149 [2014-08946]
Download as PDF
<![CDATA[
ehiers on DSK2VPTVN1PROD with NOTICES
22148
Federal Register / Vol. 79, No. 76 / Monday, April 21, 2014 / Notices
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before May 13, 2014. Oral
presentations from the public will be
scheduled between approximately 1
p.m. and 2 p.m. Those individuals
interested in making formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before May 5,
2014. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by May 6, 2014.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact James Clark
at James.Clark@fda.hhs.gov, or 301–
796–5293 at least 7 days in advance of
the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: April 15, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–08970 Filed 4–18–14; 8:45 am]
BILLING CODE 4160–01–P
VerDate Mar<15>2010
15:19 Apr 18, 2014
Jkt 232001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0001]
Request for Notification From Industry
Organizations Interested in
Participating in the Selection Process
for Nonvoting Industry
Representatives; Reopening of
Notification Period
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; reopening of comment
period.
The Food and Drug
Administration (FDA) is reopening the
period for industry organizations
interested in participating in the
selection of nonvoting industry
representatives to represent the interests
of the pharmaceutical manufacturing
industry and the pharmacy
compounding industry on the Pharmacy
Compounding Advisory Committee for
the Center for Drug Evaluation and
Research to notify FDA of such interest.
FDA announced a request for
notification of interest in selection of
industry representatives and for
nominations in the Federal Register on
January 13, 2014. This notice requested
industry organizations that were
interested in participation in the
selection process to notify FDA in
writing by February 12, 2014, and stated
that nominations would be accepted for
the two nonvoting vacancies by the
same date. Industry organizations that
did not notify FDA by the deadline of
their interest in participating in the
selection of nonvoting pharmacy
compounding and pharmaceutical
manufacturing industry representatives
have now expressed interest in
participating. Therefore, FDA is
reopening the notification period for an
additional two weeks so that any
interested industry organizations
wanting to participate can notify the
Agency of their interest.
DATES: Any industry organization
interested in participating in the
selection of appropriate nonvoting
members to represent the interests of the
pharmacy compounding industry and
the pharmaceutical manufacturing
industry on the Pharmacy
Compounding Advisory Committee
should send a letter stating the interest
to FDA by May 5, 2014, for the
vacancies announced in the Federal
Register on January 13, 2014 (79 FR
2177).
SUMMARY:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
All letters of interest should
be submitted electronically to PCAC@
fda.hhs.govmailto:, or in writing by mail
to Jayne E. Peterson, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Avenue, Bldg. 31, Rm. 2417,
Silver Spring, MD 20993.
FOR FURTHER INFORMATION CONTACT:
Jayne E. Peterson, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417,
Silver Spring, MD 20993, 301–796–
9001, FAX: 301–847–8533, email:
PCAC@fda.hhs.gov.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
ADDRESSES:
Dated: April 15, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–08968 Filed 4–18–14; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Fogarty
International Center Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Fogarty International
Center Advisory Board.
Date: May 13, 2014.
Closed: May 13, 2014 8:00 a.m. to 9:45 a.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\21APN1.SGM
21APN1
Federal Register / Vol. 79, No. 76 / Monday, April 21, 2014 / Notices
Place: National Institutes of Health,
Lawton L. Chiles International House,
Bethesda, MD 20892.
Open: May 13, 2014 10:00 a.m. to 4:00 p.m.
Agenda: Update and discussion of current
and planned FIC activities, including global
health studies, programs, and
implementation of the Strategic Plan.
Place: National Institutes of Health,
Lawton L. Chiles International House,
Bethesda, MD 20892.
Contact Person: Robert Eiss, Public Health
Advisor, Fogarty International Center,
National Institutes of Health, 31 Center Drive,
Room B2C02, Bethesda, MD 20892, (301)
496–1415, EISSR@MAIL.NIH.GOV.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.106, Minority International
Research Training Grant in the Biomedical
and Behavioral Sciences; 93.154, Special
International Postdoctoral Research Program
in Acquired Immunodeficiency Syndrome;
93.168, International Cooperative
Biodiversity Groups Program; 93.934, Fogarty
International Research Collaboration Award;
93.989, Senior International Fellowship
Awards Program, National Institutes of
Health HHS)
Dated: April 15, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications or
contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Strategy for Finding Cases of Moderate-toSevere COPD.
Date: May 14, 2014.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7182, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Susan Wohler Sunnarborg,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7182, Bethesda, MD 20892,
sunnarborgsw@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI Short Term Medical Student Research
Experience.
Date: May 19, 2014.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7196, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Charles Joyce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA,National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7196, Bethesda, MD 20892–7924, 301–435–
0288, cjoyce@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: April 15, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–08946 Filed 4–18–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
22149
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NICHD.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
Eunice Kennedy Shriver National
Institute Of Child Health And Human
Development, including consideration
of personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, NICHD.
Date: June 6, 2014.
Closed: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31A, Conference Room 2A48, 31
Center Drive, Bethesda, MD 20892.
Contact Person: CONSTANTINE A.
STRATAKIS, MD, D(med)Sci SCIENTIFIC
DIRECTOR, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, Building 31A,
Room 2A46, 31 Center Drive, Bethesda, MD
20892, 301–594–5984, stratakc@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page:https://
www.nichd.nih.gov/about/meetings/2013/
Pages/120613.aspx, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos.93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: April 15, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–08943 Filed 4–18–14; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2014–08944 Filed 4–18–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
ehiers on DSK2VPTVN1PROD with NOTICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Mar<15>2010
15:19 Apr 18, 2014
Jkt 232001
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
National Institute of Nursing Research;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council for Nursing
Research.
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 79, Number 76 (Monday, April 21, 2014)]
[Notices]
[Pages 22148-22149]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-08946]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Fogarty International Center Advisory Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Fogarty International Center Advisory Board.
Date: May 13, 2014.
Closed: May 13, 2014 8:00 a.m. to 9:45 a.m.
Agenda: To review and evaluate grant applications.
[[Page 22149]]
Place: National Institutes of Health, Lawton L. Chiles
International House, Bethesda, MD 20892.
Open: May 13, 2014 10:00 a.m. to 4:00 p.m.
Agenda: Update and discussion of current and planned FIC
activities, including global health studies, programs, and
implementation of the Strategic Plan.
Place: National Institutes of Health, Lawton L. Chiles
International House, Bethesda, MD 20892.
Contact Person: Robert Eiss, Public Health Advisor, Fogarty
International Center, National Institutes of Health, 31 Center
Drive, Room B2C02, Bethesda, MD 20892, (301) 496-1415,
EISSR@MAIL.NIH.GOV.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.fic.nih.gov/About/Advisory/Pages/default.aspx,
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.106,
Minority International Research Training Grant in the Biomedical and
Behavioral Sciences; 93.154, Special International Postdoctoral
Research Program in Acquired Immunodeficiency Syndrome; 93.168,
International Cooperative Biodiversity Groups Program; 93.934,
Fogarty International Research Collaboration Award; 93.989, Senior
International Fellowship Awards Program, National Institutes of
Health HHS)
Dated: April 15, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-08946 Filed 4-18-14; 8:45 am]
BILLING CODE 4140-01-P
